stockrowGyre Therapeutics, Inc. (GYRE) vs Shattuck Labs, Inc. (STTK)
- Gyre Therapeutics, Inc. GYRE 4.72 +17.71%
- Shattuck Labs, Inc. STTK 4.59 +2.23%
Gyre Therapeutics, Inc. and Shattuck Labs, Inc. are both Biotechnology companies. Gyre Therapeutics, Inc. and Shattuck Labs, Inc. are of similar size ($450.6M and $425.2M). Shattuck Labs, Inc. grew revenue faster over the last twelve months: 106.5% against 13.5%. Shattuck Labs, Inc. has the higher net margin (0.00% vs −21.5%) and the lower return on invested capital (−1,230.7% vs −8.51%). Across the 16 metrics below, Gyre Therapeutics, Inc. leads on 9 and Shattuck Labs, Inc. on 7.
Valuation
Profitability
| Metric | GYRE | STTK | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.71% | 100.00% | 68.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | (21.46%) | 0.00% | 0.00% |
| Free cash flow margin | (19.94%) | 0.00% | 0.00% |
| Return on equity | (18.54%) | (39.21%) | (51.96%) |
| Return on assets | (14.49%) | (36.88%) | (46.06%) |
| Return on invested capital | (8.51%) | (1,230.74%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack